Pulmonary clofazimine crystals in two patients with the acquired immunodeficiency syndrome.
Alfandari
S
S
Chidiac
C
C
Guery
B
B
Senneville
E
E
Mouton
Y
Y
Vinocour
D
D
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000188:drug therapy*; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D002991:Clofazimine / Q000009:adverse effects* / Q000627:therapeutic use; D003460:Crystallization; D004359:Drug Therapy, Combination; D005547:Foreign Bodies / Q000175:diagnosis / Q000209:etiology; D006801:Humans; D007917:Leprostatic Agents / Q000009:adverse effects* / Q000737:chemistry / Q000627:therapeutic use; D008168:Lung / Q000000981:diagnostic imaging / Q000473:pathology*; D008297:Male; D015270:Mycobacterium avium-intracellulare Infection / Q000188:drug therapy*; D011859:Radiography
D000995:Antitubercular Agents; D007917:Leprostatic Agents; D002991:Clofazimine